Cargando…

SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients

BACKGROUND: While several studies have observed that solid organ transplant recipients experience diminished antibody responses to SARS-CoV-2 mRNA vaccination, data specific to heart and lung transplant (HT/LT) recipients remains sparse. METHODS: US adult HT and LT recipients completed their vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hallett, Andrew M., Greenberg, Ross S., Boyarsky, Brian J., Shah, Pali D., Ou, Michael T., Teles, Aura T., Krach, Michelle R., López, Julia I., Werbel, William A., Avery, Robin K., Bae, Sunjae, Tobian, Aaron A., Massie, Allan B., Higgins, Robert S.D., Garonzik-Wang, Jacqueline M., Segev, Dorry L., Bush, Errol L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society for Heart and Lung Transplantation. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349311/ https://www.ncbi.nlm.nih.gov/pubmed/34456108 http://dx.doi.org/10.1016/j.healun.2021.07.026

Ejemplares similares

Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
por: Boyarsky, Brian J., et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients
por: Strauss, Alexandra T., et al.
Publicado: (2022)

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma
por: Greenberg, Ross S., et al.
Publicado: (2021)

Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic
por: Hallett, Andrew, et al.
Publicado: (2021)

Antibody response to a third dose of SARS‐CoV‐2 vaccine in heart and lung transplant recipients
por: Alejo, Jennifer L., et al.
Publicado: (2022)

Incident COVID-19 and Hospitalizations by Variant Era Among Vaccinated Solid Organ Transplant Recipients
por: Chiang, Teresa Po-Yu, et al.
Publicado: (2023)

Letter to the editor: Six‐month antibody kinetics and durability in liver transplant recipients after two doses of SARS‐CoV‐2 mRNA vaccination
por: Chang, Amy, et al.
Publicado: (2022)

Transplantation Amid a Pandemic: The Fall and Rise of Kidney Transplantation in the United States
por: Bisen, Shivani S., et al.
Publicado: (2022)

Effects of COVID19 Pandemic on Pediatric Kidney Transplant in the United States
por: Charnaya, Olga, et al.
Publicado: (2020)

Quantifying excess deaths among solid organ transplant recipients in the COVID‐19 era
por: Massie, Allan B., et al.
Publicado: (2022)

Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine
por: Ou, Michael T., et al.
Publicado: (2021)

SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19
por: Werbel, William A., et al.
Publicado: (2022)

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination
por: Chiang, Teresa PY, et al.
Publicado: (2022)

Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses
por: Strauss, Alexandra T., et al.
Publicado: (2021)

Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics
por: Sait, Afrah S., et al.
Publicado: (2021)

Effects of COVID-19 pandemic on pediatric kidney transplant in the United States
por: Charnaya, Olga, et al.
Publicado: (2020)

Uptake and 1-year outcomes of lung transplantation for COVID-19
por: Ruck, Jessica M., et al.
Publicado: (2023)

Trends and three-year outcomes of hepatitis C virus–viremic donor heart transplant for hepatitis C virus–seronegative recipients
por: Ruck, Jessica M., et al.
Publicado: (2022)

Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort
por: Avery, Robin K., et al.
Publicado: (2021)

A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients
por: Karaba, Andrew H., et al.
Publicado: (2021)

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
por: Karaba, Andrew H., et al.
Publicado: (2022)

COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge
por: Cochran, Willa, et al.
Publicado: (2022)

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease
por: Frey, Sarah, et al.
Publicado: (2022)

Early Experiences With COVID-19 Testing in Transplantation
por: Boyarsky, Brian J., et al.
Publicado: (2020)

Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension
por: Nguyen, Michelle C., et al.
Publicado: (2021)

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients
por: Karaba, Andrew H., et al.
Publicado: (2023)

Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipients
por: Thompson, Elizabeth A., et al.
Publicado: (2023)

Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on transplantation by income level and cumulative COVID-19 incidence: a multinational survey study
por: Sandal, Shaifali, et al.
Publicado: (2022)

175 The Unfinished Journey towards Transplant Equity: an analysis of racial/ethnic disparities for children in the post-KAS era
por: Charnaya, Olga, et al.
Publicado: (2022)

A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response
por: Karaba, Andrew H., et al.
Publicado: (2022)

Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination
por: Frey, Sarah, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients
por: Mitchell, Jonathan, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on commercial airlines in the United States and implications for the kidney transplant community
por: Strauss, Alexandra T., et al.
Publicado: (2020)

Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
por: Motter, Jennifer D., et al.
Publicado: (2023)

Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
por: Hughes, Robert M., et al.
Publicado: (2023)

Quantifying infection risks in incompatible living donor kidney transplant recipients
por: Avery, Robin K., et al.
Publicado: (2020)

COVID-19 Clinical Outcomes in Solid Organ Transplant Recipients During the Omicron Surge
por: Cochran, Willa, et al.
Publicado: (2022)

The Risk of Postkidney Transplant Outcomes by Induction Choice Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

48390 Racial and Ethnic Disparities in Pediatric Kidney Transplantation - Has KAS made a difference?
por: Charnaya, Olga, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i73ksemjf729u1r4754tjd4iud